Article Text
PostScript
Letter
Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment
Statistics from Altmetric.com
Footnotes
Competing interests None.
Patient consent Obtained.
Ethics approval This study was conducted with the approval of the Ethical Committee UZ Leuven in the framework of the VLECC study.
Provenance and peer review Not commissioned; not externally peer reviewed.
Linked Articles
- PostScript